// App-Quantinova.ai

: Treatment Patterns and Outcomes in Lower-Risk, Non-Del(5q) Myelodysplastic Syndromes: Findings from a Global Real-World Medical Record Review Study

Researchers

Presenter

  • Maria Diez-Campelo

Principal Investigators

  • Aylin Yucel

  • Ravi K. Goyal

  • Rohan C. Parikh

  • Elizabeth Esterberg

  • Maria Jimenez

  • Martina Sluga-O'Callaghan

  • Dimana Miteva

  • Hong Xiao

  • Ulrich Germing

Medical Centers

  • University Hospital of Düsseldorf, Düsseldorf, Germany

  • Hematology Department, Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca, Spain

Locations

  • Germany

  • United States

  • Switzerland

  • France

  • Spain

Companies

  • RTI Health Solutions

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelodysplastic Syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

  • Global

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved